CRM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Salesforce is a buy for a beginner-focused, long-term investor with $50,000-$100,000 available, but only as a moderate conviction long-term entry rather than an aggressive all-in purchase. The stock has clear valuation support from recent analyst upgrades and strong cash generation, and the current price is close to recent support/resistance levels. Given the user's unwillingness to wait for a perfect entry, CRM is acceptable to buy now for a long-term allocation.
CRM is showing a mixed-to-improving technical setup. MACD histogram is positive and expanding, which supports short-term momentum. RSI_6 at 66.5 is near overbought but still not extreme. However, the moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, confirming the broader trend is still under pressure. Price at 166.3 is just above R1 at 164.5 and below R2 at 169.4, suggesting the stock is attempting to build a base after a pullback. The next-day and next-week trend model is positive, but the one-month pattern remains negative, so the chart favors a cautious long-term buy rather than a momentum chase.
Congress trading is balanced overall, with no clear politically driven bearish or bullish signal.
The biggest negative is the still-soft growth profile. Several analysts cut targets or stayed neutral because revenue growth remains slow and AI monetization is not expected to move the needle meaningfully in the near term. The technical trend is still bearish on longer moving averages, showing the stock has not fully repaired its downtrend. Jim Cramer also warned against chasing rebounds in Salesforce, implying the recent strength may not be sustainable immediately. The one-month pattern estimate is weak, suggesting limited near-term follow-through.
Latest quarter financials are not fully available in the provided snapshot, but analyst commentary on the most recent quarter indicates 1Q FY27 results were roughly in line, with organic growth around 7% constant currency and expectations for acceleration later in the year. The key takeaway is that growth is still modest, but margins, cash flow, and buybacks remain strong. That makes the company more attractive for long-term holders than for fast-growth investors. Since the latest quarter season referenced in the analyst notes is 1Q FY27, that is the relevant quarter for this assessment.
Analyst sentiment has recently improved but remains mixed overall. In early July, Guggenheim upgraded CRM to Buy with a $228 target, and Monness Crespi also upgraded it to Buy with a $200 target. However, on June 29 Phillip Securities downgraded to Neutral with a $166 target, reflecting concern about slow growth and delayed AI monetization. Other firms such as TD Cowen and Roth remain positive, while DA Davidson and Citi are more cautious. Wall Street is split, but the balance has shifted slightly more positive recently, with bulls arguing valuation is compelling and bears focusing on weak top-line growth.
